Quest Diagnostics Puts Up $570M For PE-Backed Lab Co.

Law360, New York (January 22, 2014, 11:43 AM EST) -- Quest Diagnostics Inc. nabbed private equity-backed Solstas Lab Partners Group in a deal worth $570 million, highlighting the diagnostic company's effort to restore growth by expanding its reach and services, according to a Wednesday statement.

Purchasing Solstas, a portfolio company of business- and health care-focused Welsh Carson Anderson & Stowe, allows New Jersey-based Quest to tap into the commercial lab company's client base throughout nine states in the Southeast, including the Carolinas, Virginia, Tennessee, Alabama and Georgia, according to a statement.

"Solstas has excellent client relationships...
To view the full article, register now.